Analysis

  • Opening up the Chinese drug market

    The Chinese pharma market has always been inward-looking, with foreign investors deterred by an unfavorable regulatory climate. However, the government has implemented a raft of reforms with a view to...

  • June’s top news stories

    Novartis completed the sale of its 36.5% stake to GSK in its consumer healthcare joint venture for $13bn, and the UK Government revealed plans to build a fully automated facility...

  • Pharma Technology Focus – Issue 72

    In this issue: Overcoming red tape in China, how to boost adoption of biosimilars in the US, a profile of global health research network TriNetX, unlocking cell-free protein synthesis, and...